[go: up one dir, main page]

DE60229646D1 - N- (1-dimethylaminocycloalkyl)methyl benzamid-derivate - Google Patents

N- (1-dimethylaminocycloalkyl)methyl benzamid-derivate

Info

Publication number
DE60229646D1
DE60229646D1 DE60229646T DE60229646T DE60229646D1 DE 60229646 D1 DE60229646 D1 DE 60229646D1 DE 60229646 T DE60229646 T DE 60229646T DE 60229646 T DE60229646 T DE 60229646T DE 60229646 D1 DE60229646 D1 DE 60229646D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
dimethylaminocycloalkyl
methyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60229646T
Other languages
English (en)
Inventor
John R Morphy
Zoran Rankovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of DE60229646D1 publication Critical patent/DE60229646D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60229646T 2001-07-17 2002-07-11 N- (1-dimethylaminocycloalkyl)methyl benzamid-derivate Expired - Fee Related DE60229646D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01117273 2001-07-17
PCT/EP2002/007892 WO2003010132A1 (de) 2001-07-17 2002-07-11 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives

Publications (1)

Publication Number Publication Date
DE60229646D1 true DE60229646D1 (de) 2008-12-11

Family

ID=8178058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229646T Expired - Fee Related DE60229646D1 (de) 2001-07-17 2002-07-11 N- (1-dimethylaminocycloalkyl)methyl benzamid-derivate

Country Status (7)

Country Link
US (1) US7126027B2 (de)
EP (1) EP1419138B1 (de)
JP (1) JP4176633B2 (de)
AT (1) ATE412628T1 (de)
DE (1) DE60229646D1 (de)
ES (1) ES2314096T3 (de)
WO (1) WO2003010132A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094808A1 (en) * 2004-03-02 2005-10-13 Bayer Healthcare Ag Regulation of human glycine transporter 2
RU2395502C2 (ru) 2004-12-09 2010-07-27 Ф.Хоффманн-Ля Рош Аг Производные фенил-пиперазин метанона
WO2006067414A2 (en) * 2004-12-23 2006-06-29 Glaxo Group Limited Glycine transport inhibitors
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
PE20061330A1 (es) * 2004-12-23 2006-12-27 Glaxo Group Ltd Compuestos derivados de benzamida como inhibidores del transportador de glicina
GB0428233D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
US7718703B2 (en) 2005-01-25 2010-05-18 Mitsubishi Tanabe Pharma Corporation Norvaline derivative and method for preparation thereof
JP5165950B2 (ja) * 2006-07-21 2013-03-21 田辺三菱製薬株式会社 医薬組成物
WO2010020548A1 (en) 2008-08-20 2010-02-25 F. Hoffmann-La Roche Ag Glyt1 receptor antagonists
JP6145109B2 (ja) * 2011-11-29 2017-07-05 ビボゾン インコーポレイテッド 新規のベンズアミド誘導体、及びこの用途
TW201427947A (zh) 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺
WO2014199960A1 (ja) * 2013-06-10 2014-12-18 大正製薬株式会社 グリシントランスポーター阻害物質
US20220233492A1 (en) * 2019-06-20 2022-07-28 Vivozon Inc. Method of preventing or treating postoperative pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975443A (en) * 1972-06-06 1976-08-17 Allen & Hanburys Limited 1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
US4346101A (en) * 1980-12-08 1982-08-24 The Upjohn Company Benzamide derivative analgesics

Also Published As

Publication number Publication date
JP2005519859A (ja) 2005-07-07
JP4176633B2 (ja) 2008-11-05
ATE412628T1 (de) 2008-11-15
ES2314096T3 (es) 2009-03-16
EP1419138B1 (de) 2008-10-29
US20040242685A1 (en) 2004-12-02
US7126027B2 (en) 2006-10-24
WO2003010132A1 (de) 2003-02-06
EP1419138A1 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
RU2205823C2 (ru) Производные бензамида, способ их получения и фармкомпозиция на их основе
NO974844D0 (no) Benzimidazolforbindelser, farmasöytiske sammensetninger som inneholder forbindelsene og deres anvendelser
DE60229646D1 (de) N- (1-dimethylaminocycloalkyl)methyl benzamid-derivate
CA2300051A1 (en) Amide derivatives for the treatment of diseases mediated by cytokines
NO941052L (no) Benzimidazolforbindelser, deres anvendelse og fremstilling
EA200600990A1 (ru) Производные бензосульфониламинопиридин-2-ила и родственные соединения в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы 1 типа (11-бета-hsd-1) для лечения диабета и ожирения
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
NO20041112L (no) 1-Substituerte-1-aminometyl-cykloalkanderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandiing av neurologiske lidelser
ATE253546T1 (de) Chalcon-derivate und medikamente die diese enthalten
RU2000131610A (ru) Производные бензамида для лечения заболеваний, опосредованных цитокинами
EP0382687A3 (de) Benzo-annellierte-N-enthaltende heterocyclische Derivate
EA200600975A1 (ru) Конденсированные гетероциклические соединения, применимые для лечения ожирения и расстройств центральной нервной системы
NO974843D0 (no) Benzimidazolforbindelser, farmasöytiske sammensetninger som inneholder forbindelsene og deres anvendelser
MXPA04003056A (es) Derivados de 4?piperidin-4-iliden-(3-carbamoilfenil)metil? benzamida y su uso para tratamiento de dolor, lesiones espinales o transtornos gastrointestinales.
DE60104697D1 (de) Sulfonamid-derivate
SE9904675D0 (sv) Novel compounds
KR950702544A (ko) 비페닐메탄 유도체 및 이를 함유하는 약제
KR960021021A (ko) 인터루킨-1β의 생성 및 종양 괴사 인자 α의 방출을 억제하기 위한 약제
TR200501142T2 (tr) 5-Kloro-2-Metoksi-N-(2-(4-Metoksi-3-Metil Aminotio Karbonilamino Sülfonilfenil)Etil)Benzamid Sodyum Tuzunun Kristalin Biçimleri.
RU2020138692A (ru) Производные тетрагидропиранооксазина, характеризующиеся селективной ингибирующей активностью в отношении bace1
TH66471A (th) N-ยูรีอิโดแอลคิล-พิเพอริดีนในฐานะสารปรับแอคติวิตีของคีโมไคน์รีเซปเตอร์
TH65070A (de)
TH50274A (th) ระบบโพลิไซคลิค 2-อะมิโนไดไฮโดรไธอาโซล กรรมวิธีสำหรับการเตรียมระบบดังกล่าว และการใช้ระบบเหล่านี้เป็นเภสัชภัณฑ์

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee